MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

A study of depressed individuals found that an eight‐week treatment with selective serotonin reuptake inhibitors (SSRIs) ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

Gate Neurosciences today announced it has entered a definitive agreement to acquire Boost Neuroscience and its leading proprietary platform for human synapse network analysis and synapse-targeted drug ...

Faster-acting drugs have long been sought to protect people with severe depression who may be at risk of self-harm or suicide ...

Virginia Tech neuroscientists have uncovered a mitochondrial process that supports the brain cells critical for learning, ...

however they had concluded that no significant differences were observed in terms of depression, anxiety and stress scores, or quality of life, after lycopene supplementation. Where is lycopene ...

Tomatoes may help reduce depressive symptoms thanks to their high content of lycopene, a powerful antioxidant.